Michael L Marin
Video Visit Available
Accepting New Patients
Mount Sinai Verified Doctors IconMount Sinai DoctorsTreats Children & Adults

Michael L Marin, MD

Surgery, Vascular Surgery

White Phone Icon212-241-0737
Calender Icon
Book an Appointment
White Right Arrow

About Me

A graduate of the Mount Sinai School of Medicine, Dr. Marin completed an internship and residency at Columbia-Presbyterian Medical Center in New York; and subsequently went on to pursue a fellowship in vascular surgery at Montefiore Medical Center/Albert Einstein College of Medicine.  He remained on the faculty at Albert Einstein until 1996, when he was recruited to Mount Sinai to launch the endovascular aortic surgery program.  He was endowed as the Henry Kaufman Professor of Surgery in 1999, and appointed Chief, Division of Vascular Surgery in 2000.  In December 2003, Dr. Michael L. Marin was appointed Chairman, Department of Surgery, Mount Sinai School of Medicine and Surgeon-in-Chief of The Mount Sinai Medical Center.  In 2007, he was named The Julius H. Jacobson II, M.D. Professor of Vascular Surgery.

Dr. Marin has revolutionized modern vascular surgery.  In 1992, in New York, together with Dr. Juan Parodi from Argentina, he performed a minimally invasive repair of an abdominal aortic aneurysm under local anesthesia in an 80 year old man who had multiple medical comorbidities.  This event, the first such procedure ever performed in the United States, sparked the rapid development of new treatments by Dr. Marin and other physicians from around the world for the minimally invasive treatment of vascular disease.  Application of these techniques and new devices have been extended by Dr. Marin to virtually all areas of arterial vascular disease. Using these minimally invasive stent graft techniques and devices, Dr. Marin performed the world’s first minimally invasive repair of a popliteal and iliac artery aneurysms and, in 1994, performed the world’s first endovascular repair of a ruptured abdominal aortic aneurysm. 

Inventions and techniques resulting from Dr. Marin’s work formed the basis of 12 important U.S. patents.  In 1997, he founded the Teramed Corporation to advance the development and manufacturing of aortic stent graft devices.  Teramed was acquired by Johnson & Johnson Corporation in 2001.

An active clinician and teacher, Dr. Marin has contributed extensively to medical literature, including 200 original communications in peer-reviewed journals and more than 60 book chapters. He has served on the editorial boards of the major surgery journals, and has shared his ideas and developments as an invited lecturer throughout the United States and around the world.  He has also made over 300 presentations at scientific meetings in the United States and abroad. Additionally, he holds memberships in most regional, national and international professional societies. His achievements have garnered awards from such groups as the American Society of Gastroenterology, The Society for Vascular Surgery and The Peripheral Vascular Surgery Society.

In the News

The state of Florida requires out-of-state professionals who are registered to provide telehealth services to display a hyperlink to the Florida Department of Health telehealth web page. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.

Language
English, Spanish
Position
PROFESSOR AND SYSTEM CHAIR | Surgery, Vascular Surgery
Hospital Affiliations
  • Mount Sinai Beth Israel
  • Mount Sinai Morningside
  • The Derfner Foundation Ambulatory Surgery Center
  • Mount Sinai Brooklyn
  • Mount Sinai Queens
  • The Mount Sinai Hospital
  • New York Eye and Ear Infirmary of Mount Sinai
  • Mount Sinai West
Multi-Disciplinary Training Areas

Disease Mechanisms and Therapeutics (DMT), Genetics and Genomic Sciences [GGS]